204
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Strain Identification and Drug Resistance Analysis of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry in Nontuberculous Mycobacterial Lung Disease

, , , , , , & show all
Pages 4635-4643 | Received 20 Jan 2023, Accepted 14 Apr 2023, Published online: 17 Jul 2023

References

  • Tuberculosis Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of nontuberculous mycobacteriosis (2020 edition). Chin J Tuberculosis Respir Med. 2020;43(11):918–946. doi:10.3760/cma.j.cn112147-20200508-00570
  • Daley CL, Iaccarino JM, Lange C, et al. Treatment of Nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020;71(4):905–913. doi:10.1093/cid/ciaa1125
  • Ratnatunga CN, Lutzky VP, Kupz A, et al. The rise of non-tuberculosis mycobacterial lung disease. Front Immunol. 2020;11:303. doi:10.3389/fimmu.2020.00303
  • Liu CF, Song YM, He WC, et al. Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. Infect Dis Poverty. 2021;10(1):59. doi:10.1186/s40249-021-00844-1
  • Tan Y, Su B, Shu W, et al. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013–2016. BMC Pulm Med. 2018;18(1):168. doi:10.1186/s12890-018-0728-z
  • Liu G. Study on the Clinical Application Value of DNA Sequencing Method for Identifying Mycobacterium Species. Beijing Tuberculosis Chest Cancer Institute; 2016.
  • Ciet P, Serra G, Bertolo S, et al. Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT. Eur Radiol. 2016;26(3):780–787. doi:10.1007/s00330-015-3850-9
  • Hettick JM, Kashon ML, Simpson JP, Siegel PD, Mazurek GH, Weissman DN. Proteomic profiling of intact mycobacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem. 2004;76(19):5769–5776. doi:10.1021/ac049410m
  • Basic Professional Committee of China Antituberculosis Association. Laboratory Inspection Regulations for Tuberculosis Diagnosis. Beijing: China Culture and Education Press; 2006.
  • Zhu L, Jiang G, Wang S, et al. Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum. J Clin Microbiol. 2010;48(10):3654–3660. doi:10.1128/JCM.00158-10
  • Shi J, He G, Ning H, et al. Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients. Tuberculosis. 2022;135:102209. doi:10.1016/j.tube.2022.102209
  • Tang W, Hu J, Zhang H, Wu P, He H. Kappa coefficient: a popular measure of rater agreement. Shanghai Arch Psychiatry. 2015;27(1):62–67. doi:10.11919/j.issn.1002-0829.215010
  • Smith GS, Ghio AJ, Stout JE, et al. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006–2010. J Infect. 2016;72(6):678–686. doi:10.1016/j.jinf.2016.03.008
  • Koh WJ, Chang B, Jeong BH, et al. Increasing recovery of Nontuberculous mycobacteria from respiratory specimens over a 10-year period in a tertiary referral hospital in South Korea. Tuberc Respir Dis. 2013;75(5):199–204. doi:10.4046/trd.2013.75.5.199
  • Chu H, Zhao L, Xiao H, et al. Prevalence of nontuberculous mycobacteria in patients with bronchiectasis: a meta-analysis. Arch Med Sci. 2014;10(4):661–668. doi:10.5114/aoms.2014.44857
  • Yu F, Chen X, Ji Z, Xu K. Analysis of the prevalence of nontuberculous mycobacteria in Hangzhou from 2009 to 2014. Chin J Microecol. 2016;28(07):808–810, 815. doi:10.13381/j.cnki.cjm.201607015
  • Lotz A, Ferroni A, Beretti JL, et al. Rapid identification of mycobacterial whole cells in solid and liquid culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2010;48(12):4481–4486. doi:10.1128/JCM.01397-10
  • Morimoto K, Namkoong H, Hasegawa N, et al. Macrolide-resistant mycobacterium avium complex lung disease: analysis of 102 consecutive cases. Ann Am Thorac Soc. 2016;13(11):1904–1911. doi:10.1513/AnnalsATS.201604-246OC
  • Brown-Elliott BA, Woods GL, Kraft CS. Antimycobacterial susceptibility testing of Nontuberculous mycobacteria. J Clin Microbiol. 2019;57(10):e00834–19. doi:10.1128/JCM.00834-19
  • Huang WC, Yu MC, Huang YW. Identification and drug susceptibility testing for nontuberculous mycobacteria. J Formos Med Assoc. 2020;119 Suppl 1:S32–S41. doi:10.1016/j.jfma.2020.05.002
  • Alcaide F, Amlerová J, Bou G, et al. How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry. Clin Microbiol Infect. 2018;24(6):599–603. doi:10.1016/j.cmi.2017.11.012
  • Buchan BW, Riebe KM, Timke M, Kostrzewa M, Ledeboer NA. Comparison of MALDI-TOF MS with HPLC and nucleic acid sequencing for the identification of Mycobacterium species in cultures using solid medium and broth. Am J Clin Pathol. 2014;141(1):25–34. doi:10.1309/AJCPBPUBUDEW2OAG